Taekyung Chemical Co., Ltd. (KRX:006890)
8,840.00
-70.00 (-0.79%)
Apr 29, 2026, 3:30 PM KST
Taekyung Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 61,348 | 71,116 | 70,748 | 59,613 | 54,066 | Upgrade
|
| Other Revenue | - | -0 | -0 | -0 | - | Upgrade
|
| Revenue | 61,348 | 71,116 | 70,748 | 59,613 | 54,066 | Upgrade
|
| Revenue Growth (YoY) | -13.74% | 0.52% | 18.68% | 10.26% | 14.89% | Upgrade
|
| Cost of Revenue | 45,960 | 43,593 | 39,560 | 36,739 | 31,246 | Upgrade
|
| Gross Profit | 15,388 | 27,524 | 31,188 | 22,875 | 22,820 | Upgrade
|
| Selling, General & Admin | 12,421 | 12,826 | 12,460 | 11,491 | 9,676 | Upgrade
|
| Amortization of Goodwill & Intangibles | 8.63 | 8.01 | 9.43 | 8.96 | 7.31 | Upgrade
|
| Other Operating Expenses | 112.11 | 195.28 | 125.9 | 159.73 | 117.07 | Upgrade
|
| Operating Expenses | 13,325 | 13,818 | 13,311 | 12,474 | 10,685 | Upgrade
|
| Operating Income | 2,063 | 13,706 | 17,877 | 10,401 | 12,135 | Upgrade
|
| Interest Expense | -889.45 | -18.49 | -9.52 | -8.22 | -12.45 | Upgrade
|
| Interest & Investment Income | 2,025 | 2,758 | 3,269 | 2,370 | 1,911 | Upgrade
|
| Earnings From Equity Investments | - | -192.77 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 8.25 | 81.47 | -11.81 | -7.27 | -8.39 | Upgrade
|
| Other Non Operating Income (Expenses) | 875.87 | 44.53 | 120.38 | 50.5 | 127.1 | Upgrade
|
| EBT Excluding Unusual Items | 4,083 | 16,379 | 21,246 | 12,806 | 14,152 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2,988 | -585.88 | 1,188 | -808.49 | -189.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.06 | 1.38 | -9.76 | 40.95 | 18.12 | Upgrade
|
| Asset Writedown | 18.55 | -716.28 | -770.77 | - | - | Upgrade
|
| Pretax Income | 7,087 | 15,078 | 21,654 | 12,038 | 13,981 | Upgrade
|
| Income Tax Expense | -1,660 | 2,447 | 4,282 | 3,306 | 3,066 | Upgrade
|
| Earnings From Continuing Operations | 8,747 | 12,631 | 17,372 | 8,732 | 10,915 | Upgrade
|
| Minority Interest in Earnings | - | -15.04 | 47.29 | 135.12 | - | Upgrade
|
| Net Income | 8,747 | 12,616 | 17,419 | 8,868 | 10,915 | Upgrade
|
| Net Income to Common | 8,747 | 12,616 | 17,419 | 8,868 | 10,915 | Upgrade
|
| Net Income Growth | -30.67% | -27.58% | 96.44% | -18.75% | 41.12% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | 0.22% | 0.01% | - | - | -0.19% | Upgrade
|
| EPS (Basic) | 770.00 | 1113.00 | 1536.93 | 782.40 | 963.01 | Upgrade
|
| EPS (Diluted) | 770.00 | 1113.00 | 1536.93 | 782.40 | 963.01 | Upgrade
|
| EPS Growth | -30.82% | -27.58% | 96.44% | -18.75% | 41.39% | Upgrade
|
| Free Cash Flow | -7,806 | -7,566 | 3,475 | 4,237 | 8,754 | Upgrade
|
| Free Cash Flow Per Share | -687.20 | -667.45 | 306.59 | 373.82 | 772.39 | Upgrade
|
| Gross Margin | 25.08% | 38.70% | 44.08% | 38.37% | 42.21% | Upgrade
|
| Operating Margin | 3.36% | 19.27% | 25.27% | 17.45% | 22.45% | Upgrade
|
| Profit Margin | 14.26% | 17.74% | 24.62% | 14.88% | 20.19% | Upgrade
|
| Free Cash Flow Margin | -12.72% | -10.64% | 4.91% | 7.11% | 16.19% | Upgrade
|
| EBITDA | 4,554 | 16,184 | 20,216 | 12,763 | 14,383 | Upgrade
|
| EBITDA Margin | 7.42% | 22.76% | 28.57% | 21.41% | 26.60% | Upgrade
|
| D&A For EBITDA | 2,491 | 2,478 | 2,339 | 2,362 | 2,248 | Upgrade
|
| EBIT | 2,063 | 13,706 | 17,877 | 10,401 | 12,135 | Upgrade
|
| EBIT Margin | 3.36% | 19.27% | 25.27% | 17.45% | 22.45% | Upgrade
|
| Effective Tax Rate | - | 16.23% | 19.77% | 27.46% | 21.93% | Upgrade
|
| Advertising Expenses | 2.21 | 56.66 | 112.07 | 244.39 | 16.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.